| Cell line name |
AML-2-23 |
|---|
| Accession |
CVCL_D5E7 |
|---|
| Resource Identification Initiative |
To cite this cell line use: AML-2-23 (RRID:CVCL_D5E7) |
|---|
| Comments |
Monoclonal antibody isotype: IgG1 (PubMed=6948897); IgG3 (PubMed=2441245).
Monoclonal antibody target: UniProtKB; P08571; Human CD14. |
|---|
| Species of origin |
Mus musculus (Mouse)
(NCBI Taxonomy: 10090) |
|---|
| Hierarchy |
Parent: CVCL_4032 (P3X63Ag8.653) |
|---|
| Category |
Hybridoma |
|---|
| Publications | PubMed=6752945; DOI=10.1073/pnas.79.17.5374; PMCID=PMC346899
Ball E.D., Graziano R.F., Shen L., Fanger M.W.
Monoclonal antibodies to novel myeloid antigens reveal human neutrophil heterogeneity.
Proc. Natl. Acad. Sci. U.S.A. 79:5374-5378(1982) PubMed=6948897; DOI=10.4049/jimmunol.128.3.1476
Ball E.D., Kadushin J.M., Schacter B.Z., Fanger M.W.
Studies on the ability of monoclonal antibodies to selectively mediate complement-dependent cytotoxicity of human myelogenous leukemia blast cells.
J. Immunol. 128:1476-1481(1982) PubMed=3894519; DOI=10.4049/jimmunol.135.3.1929
Maliszewski C.R., Ball E.D., Graziano R.F., Fanger M.W.
Isolation and characterization of My23, a myeloid cell-derived antigen reactive with the monoclonal antibody AML-2-23.
J. Immunol. 135:1929-1936(1985) PubMed=2441245; DOI=10.1016/0161-5890(87)90107-6
Maliszewski C.R., Currier J.S., Fisher J., Smith R.J., Fanger M.W.
Monoclonal antibodies that bind to the My23 human myeloid cell surface molecule: epitope analysis and antigen modulation studies.
Mol. Immunol. 24:17-25(1987) |
|---|
| Cross-references |
|---|
| Encyclopedic resources |
Wikidata; Q127380230
|
|---|
| Entry history |
|---|
| Entry creation | 02-May-2024 |
|---|
| Last entry update | 10-Sep-2024 |
|---|
| Version number | 2 |
|---|
